Back to Search Start Over

MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program.

Authors :
Flowers E
Aouizerat BE
Kanaya AM
Florez JC
Gong X
Zhang L
Source :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 May 17; Vol. 108 (6), pp. e306-e312.
Publication Year :
2023

Abstract

Context: MicroRNAs (miRs) are short (ie, 18-26 nucleotide) regulatory elements of messenger RNA translation to amino acids.<br />Objective: The purpose of this study was to assess whether miRs are predictive of incident type 2 diabetes (T2D) in the Diabetes Prevention Program (DPP) trial.<br />Methods: This was a secondary analysis (n = 1000) of a subset of the DPP cohort that leveraged banked biospecimens to measure miRs. We used random survival forest and Lasso methods to identify the optimal miR predictors and the Cox proportional hazards to model time to T2D overall and within intervention arms.<br />Results: We identified 5 miRs (miR-144, miR-186, miR-203a, miR-205, miR-206) that constituted the optimal predictors of incident T2D after adjustment for covariates (hazard ratio [HR] 2.81, 95% CI 2.05, 3.87; P < .001). Predictive risk scores following cross-validation showed the HR for the highest quartile risk group compared with the lowest quartile risk group was 5.91 (95% CI 2.02, 17.3; P < .001). There was significant interaction between the intensive lifestyle (HR 3.60, 95% CI 2.50, 5.18; P < .001) and the metformin (HR 2.72; 95% CI 1.47, 5.00; P = .001) groups compared with placebo. Of the 5 miRs identified, 1 targets a gene with prior known associations with risk for T2D.<br />Conclusion: We identified 5 miRs that are optimal predictors of incident T2D in the DPP cohort. Future directions include validation of this finding in an independent sample in order to determine whether this risk score may have potential clinical utility for risk stratification of individuals with prediabetes, and functional analysis of the potential genes and pathways targeted by the miRs that were included in the risk score.<br />Competing Interests: Conflicts of Interests There are no relevant conflicts to disclose.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.)

Details

Language :
English
ISSN :
1945-7197
Volume :
108
Issue :
6
Database :
MEDLINE
Journal :
The Journal of clinical endocrinology and metabolism
Publication Type :
Academic Journal
Accession number :
36477577
Full Text :
https://doi.org/10.1210/clinem/dgac714